The Viagra of heart drugs now available in the UK

	Tweet

Patients in the UK suffering from a rare life-threatening heart condition, pulmonary arterial hypertension (PAH), could soon be offered a new treatment.

Drug company Pfizer has launched Revatio for use in patients with this condition which produces abnormal pressure levels in the blood vessel that leads from the heart to the lungs.

Sufferers experience breathlessness, fainting, chest pains and tiredness.

The condition affects about 100,000 people worldwide and is most commonly seen in women between the ages of 20 and 40.

Revatio has the same active ingredient as the anti-impotence drug Viagra.

A clinical trial by the drug company found the drug reduced the blood pressure in the artery and improved the ability of PAH patients to exercise.

The launch of the new treatment follows a series of research findings showing Viagra could be effective for other medical problems in addition to impotence.

Recent research showed Viagra was beneficial in treating the inflammatory bowel disorder Crohn’s disease.

Research has also shown that the drug reduces the harmful effect of stress on the heart, and could be used to treat people with hypertrophy (enlarged heart).

Britain is the second major European market to have the product after Germany, where it went on sale in January.

The world’s biggest drug maker launched Revatio in the United States last August.

RELATED STORIES:
Prozac Use Weakens, Shrinks Young Bones   FDA sends user-fee recommendations to Congress   Drug Treats Painful Side Effect of Chemotherapy   FDA approves Exelon to treat dementia of Parkinson’s disease   Progress made toward gonorrhea vaccine   Outsourced heart study shows cheap drugs can help   Longs drugs to move meth ingredient behind counter   Ortho-McNeil to lower the price of contraceptive pills and patches   Online sexual enhancement products risky: FDA   FDA, Barr to meet on “morning-after pill” status   Priority on Propriety in Viagra Veto   Medical journal says Merck deleted Vioxx dangers

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]